First described in the early 1980s, antiphospholipid syndrome (APS) is a unique form of
acquired autoimmune thrombophilia in which patients present with clinical features of …

Antiphospholipid syndrome (APS) is an autoimmune condition characterized by the
presence of antiphospholipid antibodies (aPL) in subjects presenting with thrombosis and/or …

Objective The clinical significance of anti-phosphatidylserine/prothrombin (aPS/PT) in
antiphospholipid syndrome (APS) is still controversial. We assessed the prevalence of …

The anti-phospholipid syndrome (APS) is an autoimmune disorder characterized by
vascular thrombosis and/or pregnancy morbidity, associated with a persistent positivity for …

Antiphospholipid syndrome (APS) is an adquired autoimmune pro-thrombotic disease
characterized by arterial and/or venous thrombosis and/or fetal losses associated with the …

Background: Increasing evidence has highlighted the role of non-criteria antiphospholipid
antibodies (aPLs) as important supplements to the current criteria aPLs for the diagnosis of …

The current mainstay of treatment in patients with thrombotic antiphospholipid syndrome
(APS) is long-term anticoagulation, mainly with Vitamin K antagonist agents. Some recently …

Although neutrophil extracellular traps (NETs) have been highlighted in several systemic
inflammatory diseases, their clinical correlates and potential pathological role remain …

Antiphospholipid syndrome (APS) is a hypercoagulable state accompanied by the presence
of heterogeneous antiphospholipid antibodies (aPL), which nonspecifically affect …

Antibodies to prothrombin can be detected by ELISA using prothrombin coated onto
irradiated plates (aPT) or the phosphatidylserine/prothrombin complex as antigen (aPS/PT) …